Director Global Oncology Medical Affairs Clinical Operations (m/f/d) - #2757035
Daiichi Sankyo Europe GmbH
Date: vor 54 Minuten
Stadt: München
Vertragstyp: Ganztags
At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
About The Role
As Director, Company Sponsored Studies (CSS) within Global Oncology Medical Affairs (GOMA), you will lead the operational strategy and execution of global company-sponsored interventional and non-interventional studies and medical affairs research projects in oncology. Acting as Study Lead, you will drive study delivery from planning through close-out, ensuring compliance, quality, timelines, and budget adherence while working in a highly collaborative, cross-functional, global matrix environment.
The position can be filled at one of our European affiliates (including Canada; with a preference for placement in Germany) or the US.
Key Responsibilities
Working at Daiichi Sankyo is more than just a job – it is your chance to make a difference and change patients’ lives for the better. We can only achieve this ambitious goal together. That is why we foster a culture of mutual respect and continuous learning, with a strong commitment to inclusion and diversity. Here, you will have the opportunity to grow, think boldly, and contribute your ideas. If you have a proactive mindset and passion for addressing the needs of patients, we eagerly await your application.
About The Role
As Director, Company Sponsored Studies (CSS) within Global Oncology Medical Affairs (GOMA), you will lead the operational strategy and execution of global company-sponsored interventional and non-interventional studies and medical affairs research projects in oncology. Acting as Study Lead, you will drive study delivery from planning through close-out, ensuring compliance, quality, timelines, and budget adherence while working in a highly collaborative, cross-functional, global matrix environment.
The position can be filled at one of our European affiliates (including Canada; with a preference for placement in Germany) or the US.
Key Responsibilities
- Lead the operational planning, execution, and delivery of global oncology company-sponsored interventional and non-interventional studies and medical affairs research projects, ensuring compliance with GCP, regulatory requirements, DS policies, timelines, budgets, and quality standards
- Serve as Global Study Lead, driving cross-functional, global study teams and coordinating all relevant activities across Medical Affairs, Clinical Operations, Regulatory Affairs, Safety, Data Management, Stats., Quality, etc. as well as with external partners
- Oversee and direct CROs and external vendors from selection through study completion, ensuring effective and compliant performance management, risk mitigation, budget oversight, and high quality delivery of milestones and study objectives
- Provide strategic and operational leadership throughout the study lifecycle, including study planning, protocol development support, study start-up, execution, and final study reporting
- Represent the GOMA Company Sponsored Studies (CSS) group on global asset, program and study teams, acting as the primary point of contact for GOMA clinical operational activities and collaborating closely with internal functional teams, alliance partners and regional stakeholders
- Drive continuous improvement of clinical operations processes, systems, SOPs, and quality standards to enhance GOMA study execution and operational excellence across GOMA
- Identify, assess, and proactively manage study and program risks, ensuring appropriate mitigation strategies and effective escalation of critical issues
- Master's degree in Life Sciences is required; PhD or PharmD preferred
- Minimum of 8 years strong GxP related, international clinical operations experience in a global pharmaceutical company, and/or Contract Research Organization (CRO), preferrably within Oncology environment
- Proven experience leading global interventional and non-interventional clinical studies and working within Medical Affairs units
- Excellent knowledge of GCP, global clinical trial regulations, vendor oversight, and study management
- Self-responsibility with excellent project leadership, stakeholder management, and communication skills
- Ability to thrive in a global, cross-functional matrix organization
- Professional English, written and spoken
Working at Daiichi Sankyo is more than just a job – it is your chance to make a difference and change patients’ lives for the better. We can only achieve this ambitious goal together. That is why we foster a culture of mutual respect and continuous learning, with a strong commitment to inclusion and diversity. Here, you will have the opportunity to grow, think boldly, and contribute your ideas. If you have a proactive mindset and passion for addressing the needs of patients, we eagerly await your application.
Wie bewerbe ich mich?
Um sich für diesen Job zu bewerben, müssen Sie auf unserer Website autorisieren. Wenn Sie noch kein Konto haben, registrieren Sie sich bitte.
Veröffentlichen Sie einen LebenslaufÄhnliche Jobs
Managing Partner - Platform EMEA
Workday,
vor 2 Stunden
Your work days are brighter here. We’re obsessed with making hard work pay off, for our people, our customers, and the world around us. As a Fortune 500 company and a leading AI platform for managing people, money, and agents,...
Projektkaufmann (m/w/d)
KNDS Deutschland,
vor 2 Stunden
Unternehmensbeschreibung KNDS Deutschland entwickelt, fertigt und betreut als Systemhaus ein breit gestreutes Produktportfolio. Dazu zählen Kampfpanzer, hochgeschützte Radfahrzeuge, Artilleriesysteme, Militärbrücken, Kundenservice sowie Ausbildungslösungen. Als Teil der KNDS-Gruppe stehen wir für den Beginn der Konsolidierung der Industrie für militärische Landsysteme in...
Investment Manager Infrastructure Equity Asset Management (m|w|d)
MEAG,
vor 2 Stunden
Die MEAG ist Teil der Munich Re Group und gehört gleichzeitig zu den bedeutendsten Asset Management Gesellschaften der Welt. Wir suchen Verstärkung für unser Asset Management Team im Bereich Infrastructure Equity. Das Illiquid Asset Equity Portfolio reflektiert die MEAG-Expertise in...